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THE OPIOID EPIDEMIC IN WEST VIRGINIA 
 
       
ABSTRACT 
The rate of overdose-related to the use of licit and illicit opioids has drastically increased over the 
last decade in the U.S. The epicenter being West Virginia the highest rates of overdoses accounting 
for 41.5 deaths for 100,000 people among the 33,091 deaths in 2015. The number of people 
injecting drugs has increased from 36% in 2005 to 54% in 2015. The total U.S cost of prescription 
opioid abuse in 2011 has been estimated at $25 billion, and criminal-justice-system costs to $5.1 
billion. The reasons for this opioid epidemic incidence in WV have been a combination of 
sociocultural factors, a depressed economy, lack of education, and a high rate of prescribing and 
dispensing of prescription opioids. These strategies were evaluated through a systematic literature 
review and semi-structured interview that displayed a broad array of tactics used in West Virginia 
to keep up with the rate of related opioid overdoses.  
Keywords: Epidemic, Sociocultural factors, Management, Lack of education, Unemployment 
___________________________________________________________________________________ 
 
 
INTRODUCTION 
Historically opioid medications, used for the treatment of chronic pain, were viewed as non-
addictive substances. In the past couple years, light has been shed upon the true implications of 
using this form of medication in at risk populations. Out of the total Medicaid beneficiaries in the 
United States (U.S.) that were prescribed opioids for pain in 2010, 40% had at least one indicator 
of potentially inappropriate use; these include overlapping prescriptions for pain relievers, 
overlapping pain reliever and benzodiazepine prescriptions, long-acting or extended release 
prescription pain relievers for acute pain, and high daily doses.1  
Staggering 33,091 deaths per the total 2015 U.S. population occurred due to opioid 
overdose.2 West Virginia, has suffered, disproportionately to the other four states with the highest 
opioid overdoses in 2015 in the U.S. The states that had the highest opioid overdoses following 
West Virginia were New Hampshire (34.3 per 100,000), Kentucky (29.9 per 100,000), Ohio (29.9 
per 100,000), and Rhode Island (28.2 per 100,000).2 West Virginia contributed more deaths to the 
U.S. total in the year 2015 than any other state, with 41.5 deaths per every 100,000 people.3 
During the past seven years, major drug wholesalers including McKesson Corporation, 
Cardinal Health and AmerisourceBergen inundated the state with 780 million hydrocodone and 
oxycodone pills, which was equivalent to an astounding 433 opioid pills per resident in West 
Virginia.4 These distributors ignored regulations to report suspicious orders for controlled 
substances to the state board of pharmacy. Moreover, the board of pharmacy failed to enforce those 
same regulations, while the distributors had a blind eye turned to tiny pharmacies in southern 
counties such as Boone, Greenbrier, Logan, and Mercer that ordered 423 million opioids between 
2007 and 2012, far more than could have had been needed by patients in such small communities, 
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which yielded $17 billion to those three major drug manufacturers.5  One underlying factor that 
has escalated West Virginia’s opioid epidemic has been the disproportionate number of jobs 
requiring manual labor, like the coal mining industry jobs.6  These dangerous occupations 
commonly held by West Virginians has led to more frequent opioid prescriptions to treat the 
injuries associated to these labor-intensive jobs.7 
 West Virginia regimes have made preventive advancements in opioid misuse; however, an 
upsurge in opioid overdose rates has been occurring. Overall methadone deaths decreased by 455 
deaths of the 5,000 total deaths recorded in 2015.5 In 2010, deaths that involved other types of 
opioids, unambiguously illegal synthetics and heroin had been involved in just 8% of total 
overdose deaths and by 2015 they were involved in 18% of total overdose deaths. Furthermore, 
there were increases in heroin and synthetic drug-related deaths, there was a drop-in overdose 
death involving natural and semisynthetic opioid analgesics, including prescription drugs like 
oxycodone and hydrocodon.8 The Obama Administration, along with local and private efforts, had 
significantly increased funding to $1.1 billion for prevention and treatment programs; conversely, 
physicians still needed a fundamental alternative to treat chronic pain.3 Multiple approaches to 
tackle opioid abuse have been tried.  
 The Food and Drug Administration have restricted some widely-prescribed painkillers by 
means of limiting refills. The means of limiting prescription opioid refills has been done by 
databases that have been used to monitor the volume of pills that were distributed and what 
physicians were prescribing them. 9 Physicians that were trained in the 60s and 70s were taught to 
reserve opioids for the most severe forms of pain, which included end of life management and 
certain cancer treatments.10  Fast forward two decades where arguments have been made that 
physicians undertreated common forms of pain that could have been relieved by opioids; including 
back and joint pain.10  The argument that physicians undertreated pain initiated the movement to 
increase the prescribing of opioids for these ailments.  
 The purpose of this research was to examine and analyze the cause of the opioid epidemic 
and subsequent responses to it in the state of West Virginia. 
METHODOLOGY 
The primary hypothesis of this study was that if physicians continue to over prescribe opioids for 
chronic pain then more individuals are at risk for developing opioid dependence; therefore, 
increasing the likelihood of substance use disorders and potential overdoses. The secondary 
hypothesis of this study was that if physicians abruptly stop prescribing opioids then patients are 
at risk for entering withdrawal; therefore, increasing the likelihood of obtaining opioids through 
illegal prescriptions or using illicit opiates such as heroin. The conceptual framework used for this 
review was adapted from Shi, Stevens, Faed and Tsai (2008).11 The use of this conceptual 
framework is appropriate because both studies seek to identify factors as they relate to vulnerable 
populations (Figure 1). The conceptual framework identifies that risk factors must be present for 
individuals to develop a substance use disorder and that access to care greatly impacts the health 
outcomes of those individuals. 
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Figure 1: Conceptual Framework  
Source: Shi, Stevens, Faed and Tsai, 2008 
  
The literature review was conducted in three distinct phases. The three phases of this process were 
1) literature identification and collection, 2) literature categorization, and 3) literature analysis.  
Step 1: Literature Identification and Collection 
The literature review was conducted using Medline, PubMed, EBSCO Host, and Google Scholar 
databases. To identify articles for review, the keyword search terms were ‘opioid epidemic’ or 
‘opioid misuse and West Virginia or ‘chronic pain’ or ‘naloxone’ or ‘prevention’ or ‘response.’ 
Next, to analyze the gathered information, the results were categorized into subsections that were 
previously determined. 
Step 2: Literature Categorization 
All articles selected were in the English language. Only articles that were published in the years 
2009 to 2017 were selected from the yielded results. Articles that were chosen for further review 
were determined based upon the following criteria: demonstrated results identifying the cause of 
the opioid epidemic in West Virginia in addition to the keyword search terms.  
Step 3: Literature Analysis 
Lastly, the articles that were selected for this literature review were analyzed for information 
directly and indirectly related to the hypothesis and purpose of this paper. The results of this 
analysis and of the articles was presented in the results section of this paper. In the initial results 
and introduction 37 resources were selected. These resources were selected by RM, NB and SK. 
AC acted as a second reader and validated the resources. 
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Furthermore, a semi-structured interview was conducted after the literature was reviewed. 
The interviewee was a licensed physician practicing in the state of West Virginia. The physician 
provides both primary care and substance use treatment services. The physician was referred to as 
Expert in Opioid Dependence throughout the review.  
RESULTS 
Preventing Consequences of Opioid Misuse  
Syringe exchange for IV drug users has created an opportunity for public heath outreach workers 
to reduce the harm caused by needle sharing. This outreach has also provided an opportunity for 
those detrimentally affected by opioids to engage in conversations about treatment and recovery. 
If individuals that have been suffering from opioid dependence were also experiencing 
homelessness, a brief encounter with a syringe exchange nurse can create a valuable moment to 
educate those persons on housing assistance available within their community.12 
West Virginia has implemented harm reduction programs with much success. The Cabell 
Huntington Health Department and Kanawha- Charleston Health Department have opened syringe 
exchanges for individuals who use substances intravenously. Both health departments operate one 
clinic, one day per week. Since the start of the harm reduction program at the Kanawha -Charleston 
Health Department in December of 2015, 2,228 people have been served over 7,040 visits.13 While 
these programs have provided an opportunity for intervention and referral to treatment, they have 
also provided an opportunity to stop the spread of infectious disease, which has historically been 
a co-occurring diagnosis for individuals with substance use disorders. Common infectious diseases 
include, Hepatitis B and C, and HIV. The harm reduction programs offered needles, metal cookers, 
bottled water, condoms, gauze, tourniquets and more. The goal has been to provide individuals 
with all the supplies they need to inject substances, namely heroin, so they do not resort to sharing 
needles or using unsanitary water or other devices. Initial funding for the program was provided 
by the Department of Health and Human Resources in the amount of $10,000 with an additional 
$10,000 for technical support14. In an article published by the City of Huntington in fall 2015, Dr. 
Michael Kilkenny, Physician Director of Cabell Huntington Health Department, stated that the 
health department planned to expand the program to five more locations in the city. The expansion 
has not occurred. Funding for the program will impact future implementation throughout the 
state.13 
Lifting of Federal Ban on Needle Exchange Program 
 The ban placed on the needle exchange program was lifted during 2009 to 2011, through 
this period the number of needle exchange programs were increased. A total number of 221 
programs were reported to obtain state or local funding during the same period.15 The rate of 
exchange of needle exchanges were increased to greater than 30 million in the year 2008, according 
to the North American Syringe Exchange Network.16 Centers for Disease Control and Prevention 
(CDC), has reported that while the utilization of syringe services program, the number of people 
injecting drugs have raised from 36% in 2005 to 54% in 2015, out of which only 1 in 4 injection 
drug users have obtained all the syringes and needles from sterile sources, representing greater 
than 50% of the new drug users, and reported to have the highest rate of syringe sharing.17   
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The Centers for Disease Control and Prevention’s Prescribing Guidelines for Primary Care 
Providers 
New guidelines provided by the (CDC) that have been adopted by many institutions in West 
Virginia including all seven system hospitals and associated clinics within West Virginia 
University Medicine.18 These guidelines included using non-pharmacologic therapies, such as 
exercise and cognitive behavioral therapy, and non-opioid pharmacologic therapies, such as anti-
inflammatory medications, to treat chronic pain whenever possible.19 Prescribers that have 
followed the new CDC guidelines have enforced a start low and go slow principle, measured 
effectiveness by functional goals rather than pain severity, and monitored patients through regular 
follow-up.20  
The new CDC guidelines included a two-page prior-authorization form which was essentially 
a checklist of recommendations by the CDC. If the physicians did this, it would have allowed 
physicians to keep their patient on the current dosage that had been recommended. Likewise, 
physicians also followed a template that had encompassed an opioid treatment plan that had listed 
safe prescribing practices.21 These requirements exempted opioids prescribed to cancer and 
terminally ill patients. The CDC guidelines reported opioids should not be the first choice for 
treating chronic pain and suggested prescribing the lowest dosage possible while monitoring their 
patients closely.22 According to an Expert in Opioid Dependence, the adoption of the CDC 
Guidelines has decreased the number of opioids prescribed throughout the state; however, it may 
increase the number of individuals who were without proper treatment for their condition. The 
expert stated that the alternative treatments for these conditions can be costly to patients and 
unavailable in the state. (Appendix A). 
 
 
 
 
 
 
 
 
 
Figure 2: CDC’s Checklist for Prescribing Opioids in Primary Care 
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Source : DHHS, n.d23 
Licensing of Chronic Pain Clinics in West Virginia 
For facilities to have met the definition of a pain clinic, more than 50% of the patients in 
the practice during any one-month period had been treated for chronic pain for non-cancer 
conditions which made them eligible for licensure thereafter. Moreover, licensure has ensured that 
all chronic pain management clinics conformed to common set of standards and has required 
minimum requirements for treatment, safety, and comfort of patients.24 
The Chronic Pain Licensing Act stated that the designated physician owner of an opioid 
based clinic must have completed a pain medicine fellowship that has been accredited by the 
Accreditation Council for Graduate Medical Education or such other similar program or was 
certified by the American Board of Pain Medicine or current board certification by the American 
Board of Anesthesiology.25 
Senate Bill 4035: Provision of the Distribution for Naloxone to the General Public 
The purpose of this bill was to permit pharmacists to supply Naloxone Hydrochloride in 
agreement with standardized procedures or protocols that have been set in place by the West 
Virginia Board of Pharmacy and the West Virginia Board of Medicine.26 The cost of Naloxone 
has cost anywhere between $100 and $3,700 each time it is purchase from the pharmacy. The 
range of price has been more depended on the manufacturer and the way it was administered.27 
Every person that purchased Naloxone from a pharmacy must be trained by a pharmacist on how 
to recognize an overdose. Similar to the syringe exchange, this bill has been expected to bring 
people suffering from addiction one step closer to treatment opportunities, while systematically 
reducing societal costs of opioid addiction.28 Local emergency medical agencies have administered 
4,186 doses of Naloxone in the year 2016; this was an increase from 3,351 doses of Naloxone in 
2015.27 West Virginia received a $1 million federal grant that implemented a project that provided 
more than 4,000 of two-dose kits that were dispersed to high priority areas; these areas included 
needle exchange programs as well as police and fire departments in the major cities of Huntington, 
Charleston, Wheeling, and Morgantown and rural areas of West Virginia.29 
Programs such as this have faced several critical barriers. Naloxone’s prescription status 
created many questions about how the drug can be made available to drug users or others who may 
be in a position to help.30 A total of 53,032 individuals from 1996-2010 were trained in naloxone 
administration and overdose response. Further, a total of 10,171 overdose reversals were reported 
between 1996 and 2010.31 
Financial Impact of Opioid Epidemic in the U.S 
  The Institute of Medicine has reported that a total number of 116 million Americans had 
suffered with the persistence of pain from weeks to years and has resulted in a financial crisis 
ranging from $560 billion to $635 billion per year in medical treatment, lost productivity.32,33 In 
the U.S, approximately 240 million opioid prescriptions were dispensed in the year 2015 which 
accounted for one for every adult in the general population.34The total economic burden from the 
prescription opioid overdose was projected to be $78.5 billion for the year 2013. Approximately 
one-third of the total costs which was $28.9 billion was due to the augmented health care costs and 
substance abuse treatment costs. The public-sector costs in healthcare, substance abuse treatment, 
and criminal justice costs were projected to be around one-fourth, $19.6 billion.35 
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DISCUSSION 
This study was created with the intention to compile and evaluate literature regarding the 
opioid epidemic in West Virginia and current responses. West Virginia has been at the epicenter 
of this epidemic with the highest rates of overdose, 41.5 deaths per 100,000 people.3 Both the 
literature review and semi-structured interview showed that West Virginia has developed 
promising responses to the epidemic, but efforts have fallen short as evident by the continued climb 
of the overdose rates in the state. With the highest rate of overdose in the nation, a comprehensive 
approach to addressing this issue is crucial.  
The initial findings have suggested that in response to the opioid epidemic, West Virginia 
has utilized prevention efforts, widely distributed naloxone, enacted and enforced the regulation 
of chronic pain clinics, which were identified as a contributing factor to the large misuse of 
prescription opioid medications. The needle exchange programs have depended on the funding 
from state and local funding also as a result of federal ban for several years. These programs have 
offered needles to intravenous drug users and a means to minimize the spread of HIV/AIDS With 
an aim to minimize the harm and address the opioid epidemic. 
There has been significant impact on the society with the drug abuse with respect to clinical 
and economic burden. The drug overdose has resulted in 830,652 years of loss of the potential life 
under the age of 65 years which was like the many years of the lives lost from the motor vehicle 
accidents. The increase in the number of deaths have explained the wide spread occurrence of the 
opioid over usage. The pain prescription spending in the U.S has increased to greater than $9 
billion spending every year, drug abuse costs to the U.S government was estimated to be $300 
billion in a year.36 Even though the treatment of opioid abuse has positive effect on the society, 
there has been a significant effect on the payers of both public and private sectors due to increase 
in costs. 
The interview with the Expert revealed that the responses to the opioid epidemic analyzed in 
the results do not address the current population with substance use disorders that are without 
treatment services. The expert supported their opinions with experience both as a primary care 
physician and a physician who has treated opioid dependence in the state. It was identified that the 
three main contributing factors to the opioid epidemic have been 1) the mental health status of the 
state’s population, 2) labor intensive occupations, and 3) the financial incentive that accompanies 
the distribution of prescription opioids and illicit opiates, both legally and illegally (Appendix A). 
The responses to the opioid epidemic have not addressed the contributing factors identified by the 
expert. To appropriately respond, an increase in access to care for both physical and mental health 
conditions is required.  The expert further stated that funding is crucial to addressing this epidemic. 
Funding directly ties to the practical implications of this study. According to the Substance Abuse 
and Mental Health Services Administration (SAMHSA) West Virginia was allocated $5.8 million 
for State Opioid Response Grant. While West Virginia received this assistance, bordering states 
such as Kentucky and Ohio received double and quadruple that amount based upon their 
population size. West Virginia DHHR has been responsible for distributing this funding to areas 
of need. The distribution has required careful consideration, of the needs of the population and the 
political climate. This funding has provided much needed help; however, grant funding has 
historically initiated services with the notion that they will sustain themselves by other means such 
as health insurance reimbursement.  The threat to repeal the Affordable Care Act has drastically 
impacted the success of the implementation of these services and future treatment options. Many 
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of the participants in Substance Use Treatment Programs have Medicaid, and many of them 
received it through the expansion. Without health insurance those individuals will be at risk for 
not being able to afford treatment services. An additional barrier to implementing these strategies 
to address the epidemic is the lack of education and awareness about ongoing efforts including 
overdose prevention. Lack of robust research and resources hampered many of the existing 
programs and prevented their scale-up. Law enforcement and political actors also have opposed 
the initiatives for the fear of enabling or sanctioning illegal drug use, while witnesses of overdoses 
involving illegally-obtained drugs avoided summoning emergency response.37 
The literature review has multiple limitations including researcher bias, publication bias, 
and search strategy. The researches of this study are subject to bias due to previous knowledge and 
opinions on the subject matter. The articles selected for further review are impacted by this bias. 
Publication bias was also a limitation in this study. Articles with statistical significance were 
selected for publication at a higher rate than those without. The documented response to the opioid 
epidemic has recently begun; therefore, many statistics on the impact of these strategies has not 
been evaluated. The search strategy impacted the availability of articles for review, as the 
researches only utilized four databases.  
 
CONCLUSION 
The current efforts implemented to address the opioid epidemic have led to increased 
education and awareness about overdose reversal and safe prescribing practices. While the 
overdose rate continues to climb, the number of strategies employed is increasing. Over the next 
few years West Virginia will spend time initiating new strategies and expanding upon old ones 
with the addition of federal funding. 
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Questions Asked in Semi-Structured Interview of a Primary Care Physician and Expert in 
Substance Use Treatment on March 30th, 2017. 
 
• If you had to narrow down the cause of the Opioid Epidemic in West Virginia to three main 
contributing factors what would they be? 
 
• In your professional opinion, are there alternatives to treating chronic pain with opioids? 
 
• How often do you see those patients that are prescribed opioids and how far apart are your 
follow up appointments for those same patients? 
 
• When treating patients with Suboxone, do you notice a difference between patients who 
are dependent on prescription opioids vs. heroin?  
 
• What is the most challenging aspect about treating opioid dependence in West Virginia? 
 
• Do you think the West Virginia’s adoption of the CDC Guidelines for Prescribing Opioids 
in Primary care will reduce the number of individuals treated with chronic pain? What 
challenges do you foresee with these guidelines? 
 
 
